Its net profit fell to RON960,000, from RON1.3 million in the first three months of 2013.

Farmaceutica Remedia revenue rose 2% in the first quarter, to RON63.9 million, while expenses also increased 3% to RON62.8 million.

The company expects a profit of RON2.7 million this year, 10% lower than in 2013, and net revenues from sales of RON258.5 million, up 7% on the year.

The pharmaceutical company reported a net profit of RON3.03 million last year, 45% lower than in 2012, while its turnover stagnated at RON237.83 million, according to the company’s preliminary earnings report.

Remedia seeks to reach a network of over 90 drugstores this year, from its current 85. According to previous company data, Remedia has a market share of less than 2%.

According to the latest available data, board chairman Valentin Norbert Tarus owns a 66.5% stake in the company and businessman Lutz Stache indirectly holds a 16.49% stake.